Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZNCF) Prepaid Assets (2016 - 2024)

Historic Prepaid Assets for Astrazeneca (AZNCF) over the last 10 years, with Q4 2024 value amounting to $1.7 billion.

  • Astrazeneca's Prepaid Assets rose 742.12% to $1.7 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $1.7 billion, marking a year-over-year increase of 742.12%. This contributed to the annual value of $1.7 billion for FY2024, which is 742.12% up from last year.
  • Per Astrazeneca's latest filing, its Prepaid Assets stood at $1.7 billion for Q4 2024, which was up 742.12% from $1.6 billion recorded in Q4 2023.
  • Over the past 5 years, Astrazeneca's Prepaid Assets peaked at $1.7 billion during Q4 2024, and registered a low of $706.0 million during Q1 2021.
  • In the last 5 years, Astrazeneca's Prepaid Assets had a median value of $1.6 billion in 2021 and averaged $1.4 billion.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 10057.8% in 2020, then tumbled by 1285.3% in 2021.
  • Astrazeneca's Prepaid Assets (Quarter) stood at $1.7 billion in 2020, then decreased by 12.85% to $1.5 billion in 2021, then fell by 12.1% to $1.3 billion in 2022, then increased by 21.67% to $1.6 billion in 2023, then rose by 7.42% to $1.7 billion in 2024.
  • Its Prepaid Assets was $1.7 billion in Q4 2024, compared to $1.6 billion in Q4 2023 and $1.3 billion in Q4 2022.